Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic ...
Galectin Therapeutics Inc. (NASDAQ:GALT), a clinical-stage biotechnology company developing therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today ...
Data from the NAVIGATE trial presented at EASL 2026 (May 27–30, Barcelona) oral presentation demonstrates belapectin reduces varices development ...
Detailed price information for Galectin Therapeutic (GALT-Q) from The Globe and Mail including charting and trades.
Barrett’s esophagus is a tissue change in the esophagus caused by long-term gastroesophageal reflux disease (GERD). Only 0.5% of people with Barrett’s are diagnosed with esophageal cancer each year.
There is no reliable treatment for ineffective esophageal motility (IEM), a disorder caused by failed smooth-muscle contraction that is common in patients with gastroesophageal reflux disease.
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
The main nerve of your parasympathetic nervous system (PNS), your vagus nerve relays messages between your brain, digestive system, and heart. Your PNS helps your body relax and recover after stress - ...
Robert Burakoff, MD, MPH, is a board-certified gastroenterologist who serves as vice chair of Ambulatory Services at Lower Manhattan Hospital and professor of medicine at the Weill Cornell Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results